QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
LON:AVO

Advanced Oncotherapy plc (AVO.L) Share Forecast, Price & News

GBX 40.50
-0.50 (-1.22 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
40.30
Now: GBX 40.50
41.50
50-Day Range
31.22
MA: GBX 39.01
47.50
52-Week Range
20
Now: GBX 40.50
50
Volume36,526 shs
Average Volume327,437 shs
Market Capitalization£135.16 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Advanced Oncotherapy plc (AVO.L) logo

MarketRank

Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-36178728
Employees129
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 1.78 per share
Book ValueGBX 17.60 per share

Profitability

Miscellaneous

Market Cap£135.16 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 40.50
-0.50 (-1.22 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVO News and Ratings via Email

Sign-up to receive the latest news and ratings for AVO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Advanced Oncotherapy plc (AVO.L) (LON:AVO) Frequently Asked Questions

How has Advanced Oncotherapy plc (AVO.L)'s stock price been impacted by COVID-19?

Advanced Oncotherapy plc (AVO.L)'s stock was trading at GBX 32.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVO stock has increased by 24.6% and is now trading at GBX 40.50.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Advanced Oncotherapy plc (AVO.L)?

Wall Street analysts have given Advanced Oncotherapy plc (AVO.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Advanced Oncotherapy plc (AVO.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Advanced Oncotherapy plc (AVO.L)'s earnings last quarter?

Advanced Oncotherapy plc (AVO.L) (LON:AVO) released its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.
View Advanced Oncotherapy plc (AVO.L)'s earnings history
.

Who are some of Advanced Oncotherapy plc (AVO.L)'s key competitors?

What other stocks do shareholders of Advanced Oncotherapy plc (AVO.L) own?

Who are Advanced Oncotherapy plc (AVO.L)'s key executives?

Advanced Oncotherapy plc (AVO.L)'s management team includes the following people:
  • Dr. Michael Jeffrey Sinclair, Exec. Chairman (Age 78, Pay $554.93k)
  • Mr. Nicolas Serandour, CEO & Exec. Director
  • Prof. Stephen Myers, Exec. Director (Age 74, Pay $255.69k)
  • Mr. Ed Lee, COO & Pres of Europe
  • Mr. Graham Pughe, Sr. Vice-Pres of Accounting
  • Dr. Manuel Gallas, Director of Technical & Engineering
  • Mr. David Navas, VP of Investor and PR
  • Ms. Bridget Biggar, Director of HR
  • Ms. Donatella Ungaro, Managing Director of ADAM
  • Ms. Marina Giunta, Head of Physics Group

What is Advanced Oncotherapy plc (AVO.L)'s stock symbol?

Advanced Oncotherapy plc (AVO.L) trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy plc (AVO.L)?

Shares of AVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Advanced Oncotherapy plc (AVO.L)'s stock price today?

One share of AVO stock can currently be purchased for approximately GBX 40.50.

How big of a company is Advanced Oncotherapy plc (AVO.L)?

Advanced Oncotherapy plc (AVO.L) has a market capitalization of £135.16 million. Advanced Oncotherapy plc (AVO.L) employs 129 workers across the globe.

What is Advanced Oncotherapy plc (AVO.L)'s official website?

The official website for Advanced Oncotherapy plc (AVO.L) is www.advancedoncotherapy.com.

How can I contact Advanced Oncotherapy plc (AVO.L)?

Advanced Oncotherapy plc (AVO.L)'s mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The company can be reached via phone at +44-20-36178728.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.